http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f0752e22097e3eede75ed62ddb1c403
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Earl |
| name | Helena M. Earl Helena M Earl |
| given-name | Helena M. Helena M |
| organization-name | Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: hme22@cam.ac.uk. Oncology Centre, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK; University of Cambridge Department of Oncology & NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; 4Cambridge Experimental Cancer Medicine Centre, Cambridge; 5Warwick Clinical Trials Unit, University of Warwick; and 6Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; 4Cambridge Experimental Cancer Medicine Centre, Cambridge; 5Warwick Clinical Trials Unit, University of Warwick; and 6Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom Cambridge Experimental Cancer Medicine Centre, Cambridge, UK,; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, United Kingdom, CB2 0QQ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, United Kingdom, CB2 0QQ Oncology Centre, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK; University of Cambridge Department of Oncology, Oncology Centre, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: hme22@cam.ac.uk. University of Cambridge and National Institute of Health Research Cambridge Biomedical Research Centre, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 0QQ, UK. Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom University of Cambridge; and National Institute of Health Research, Cambridge Biomedical Research Centre at Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn,... University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: hme22@cam.ac.uk. |
Incoming Links
Total number of triples: 76.